Evidence map›Paper›PMID 34657981›Full record

ArticleParasitology research2021

A proteomics evaluation of the primary and secondary immune response of Biomphalaria straminea challenged by Schistosoma mansoni.

Nairomberg Cavalcanti Portela Junior, Elverson Soares de Melo, Iasmim Lopes de Lima, Rubens Emanoel Tavares da Rocha, Michel Batista, Roberto Afonso da Silva, Ana Paula Sampaio Feitosa, Jose Luiz de Lima Filho, Fábio André Brayner, Luiz Carlos Alves

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nairomberg Cavalcanti Portela JuniorKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil. nairomberg.portela@ufpe.br.ORCID http://orcid.org/0000-0002-5392-857X
Elverson Soares de MeloDepartment of Parasitology, Aggeu Magalhães Research Center FIOCRUZ Pernambuco, Professor Moraes Rego Avenue, s/n-Campus da UFPE-Cidade Universitária, Recife, PE, CEP: 50.740-465, Brazil.
Iasmim Lopes de LimaKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Rubens Emanoel Tavares da RochaKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Michel BatistaCarlos Chagas Institute FIOCRUZ Paraná, Mass Spectrometry Facility P02-004, Professor Algacyr Munhoz Mader street, 3775 - Curitiba Industrial City, Curitiba, PR, CEP: 81,350,010, Brazil.
Roberto Afonso da SilvaKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Ana Paula Sampaio FeitosaKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Jose Luiz de Lima FilhoKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Fábio André BraynerKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Luiz Carlos AlvesKeiso Asami Imunopatology Laboratory, UFPE, Prof. Moraes Rego Avenue, 1235 - Unversitary City, Recife, PE, CEP: 50,670-901, Brazil.
Universidade Federal de Pernambuco · BRCentro de Estudos e Pesquisas em Educação, Cultura e Ação Comunitária · BRInstituto de Biologia Molecular do Paraná · BR

Funding

Centro de Pesquisas Aggeu Magalhães, Fundação Oswaldo Cruz 1658-2.13/15Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco 0279-2.13/15
6 · The paper itself

Abstract

Biomphalaria spp. snails are intermediary hosts of Schistosoma mansoni, etiologic agent of intestinal schistosomiasis, one of the most important neglected tropical diseases. Biomphalaria straminea is an important intermediary host that possess a different phenotype to parasite infection but shows a large geographic distribution and high capacity of new ecologic niche invasion. Our purpose was to characterize for the first time the differentially expressed proteome in B. straminea during two times intervals after primary and secondary exposure to S. mansoni. The hemolymph was collected at 1 and 15 days after primary and secondary exposure of snails to the parasite. Total proteins were extracted and digested with trypsin. LC-MS/MS label-free quantification was performed and analyzed using Maxquant and Perseus software. Proteins were identified and annotated using Blast2GO tools. After 1 day of exposure, most of upregulated proteins are hemoglobin type 2, C and H type lectins, molecules related to cell adhesion, and response to oxidative stress. After 15 days, we found a similar pattern of upregulated proteins but some fibrinogen-related proteins (FREPs) and TEPs homologs were downregulated. Regarding the differentially expressed proteins during secondary response, the principal immune-related proteins upregulated were C and H type lectins, cellular adhesion molecules, biomphalysin, and FREP3. We noted a several upregulated biological processes during both responses that could be the one of the key points of efficacy in the immune response to parasite. Our data suggests different immune mechanisms used by B. straminea snails challenged with S. mansoni.

Indexed as

BiomphalariaSchistosomiasis mansoniAnimalsChromatography, LiquidImmunologic MemoryProteomicsSchistosoma mansoniTandem Mass SpectrometryBiomphalariaDifferential expressionHemolymphImmune primingImmune responseInnate immune memoryProteomicsSchistosoma

Identifiers

PMID34657981
OpenAlexW3205289999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.